Connect with us

Business

Asian shares open higher following stellar month of gains – Reuters

Published

 on


Healthcare

Paulina Duran
Jessica DiNapoli

(Corrects to China’s index, not futures, in paragraph 3)

SYDNEY/NEW YORK, Dec 1 (Reuters) – Asian share markets opened slightly higher on Tuesday buoyed by the prospect of a COVID-19 vaccine, reversing the previous day’s dips as investors took profits at the end of a record-breaking month.

MSCI’s broadest index of Asia-Pacific shares outside Japan added 0.26% on Tuesday after closing the month 9% higher, the best November since 2001. Japan’s Nikkei and Australia’s S&P/ASX 200 were each 0.9% higher, while South Korea was up 1.4%.

China’s blue-chip CSI300 index was 0.72% higher on Tuesday, after data on Monday that pointed to a continued recovery in the world’s second-largest economy against the backdrop of the COVID-19 pandemic.

“We’ve seen clearly a huge wave of liquidity coming to equities in response to the vaccine news and in response to U.S. election news,” said Hamish Tadgell, a portfolio manager at SG Hiscock & Company.

“But there are still risks, and as a result we could see the market pull back, I think, particularly as we come into sort of the Christmas period.”

Wall Street was weaker on Monday, partly driven by a rebalancing of portfolios, as investors cashed in on gains after a strong month punctuated by updates of COVID-19 vaccines progressing and hopes of a swift economic rebound next year.

“There was profit taking around the world so we ended a record month with a whimper not a bang, and you know, taking a little bit of a breather,” said Interactive Brokers Chief Strategist Steve Sosnick.

“I think that markets are pricing in, if not fully pricing a recovery, they are pricing in the vast majority of it (and) it’s very hard to meet these elevated expectations.”

MSCI’s gauge of stocks across the globe was roughly flat. Hong Kong’s Hang Seng index futures were down 0.36%, while China’s CSI 300 futures were 0.36% higher.

In the United States the Dow Jones Industrial Average fell 0.91% on Monday while the S&P 500 lost 0.46%. The tech-heavy Nasdaq Composite ended down 0.06%.

Moderna Inc applied for U.S. emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns.

“U.S. markets were a little bit lower, that’s what was holding us back a little bit,” said Chris Weston, head of research at Melbourne brokerage Pepperstone. “People are pretty optimistic for a good 2021.”

The dollar was under pressure on Tuesday, after closing out its worst month since July with a little bounce and as investors reckon on even more U.S. monetary easing.

Oil prices were slightly lower on uncertainty about whether the world’s major oil producers would agree to extend deep output cuts at talks this week.

U.S. crude eased back 11 cents to $45.23 a barrel on Tuesday, while Brent crude futures were largely unchanged at $47.86.


© 2020 Reuters. All Rights Reserved.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

COVID-19: No Moderna or Pfizer vaccine deliveries for B.C. in last week of January – Vancouver Sun

Published

 on


Article content continued

The provincial health officer, Dr. Bonnie Henry, said that 40 per cent of B.C.’s Moderna doses had been used so far. Moderna vaccine is stored at a higher temperature than Pfizer’s so is easier to deliver outside Metro Vancouver.

So far, 80 per cent of the roughly 92,000 doses delivered in B.C. have been from Pfizer and the rest from Moderna.

There were 465 cases of COVID-19 reported on Monday and 12 deaths.

There are 4,331 active cases, with 329 being treated in hospital, including 70 in intensive care.

There were no new outbreaks in health care facilities or in the community. An outbreak at The Emerald at Elim Village in Surrey is over with no deaths, leaving 58 active outbreaks in health care facilities.

B.C.’s provincial state of emergency was extended until Feb. 2.

There have been 693 tickets with fines issued, that include 548 for people refusing to comply with a directive, 119 for unlawful gatherings and 26 for violation of provincial health officer liquor rules.

Authorities have issued 85 tickets for people who breached the mandatory two-week quarantine for anyone entering B.C. from outside Canada.

dcarrigg@postmedia.com

twitter.com/davidcarrigg


Get the latest COVID-19 news delivered to your inbox weeknights at 7 p.m. by subscribing to our newsletter here.


CLICK HERE to report a typo.

Is there more to this story? We’d like to hear from you about this or any other stories you think we should know about. Email vantips@postmedia.com.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Pfizer to halt COVID vaccine deliveries to Canada next week, making worse already slow rollout

Published

 on

Conservative health critic Michelle Rempel Garner said the Liberals had to come clean about the full details of the rollout, so Canadians could see how it stood up to scrutiny.

“When they say that every Canadian will have a dose of vaccine by September, what assumptions have they made on approval, timelines, and availability of other vaccine candidates and if those don’t come to pass what’s plan B?”

She said she wanted the government to succeed, so Canadians could get back to a normal life, but that clearly had not happened.

“I really don’t take any pleasure in saying that they haven’t delivered.”

According to the Bloomberg news service, as of Monday, Canada was 12th in the world on vaccines delivered on a per capita basis. Behind countries like Israel, the U.K. and the United States and the United Arab Emirates, as well as several small European countries.

Israel is the world leader so far having administered first doses to more than 25 per cent of its population primarily using the Pfizer vaccine. Several reports indicated the country had paid more for the vaccines than other countries. it also had agreed to share anonymized patient data from its health system with Pfizer.

The United Kingdom has approved the AstraZeneca vaccine and made it a major part of its rollout. The vaccine, which is not yet approved in either Canada or the United States, does not need to be kept frozen and is easier to distribute. Some countries, like the United Arab Emirates, that are ahead of Canada are using a vaccine from Sinopharm, a Chinese state company.

Trudeau was asked Tuesday why Canada hadn’t ordered more doses for the first quarter of the year. He said there were only so many doses available from the two approved candidates Pfizer and Moderna, before the vaccines were approved and manufacturing could ramp up.

“The challenge is, as of December 1, 2020, there were none of these vaccines being produced anywhere in the world for general use. They were all in testing and trials in the scientific community,” he said.

• Email: rtumilty@postmedia.com | Twitter:

Source: – National Post

Source link

Continue Reading

Business

Pfizer to halt COVID vaccine deliveries to Canada next week, making worse already slow rollout – National Post

Published

 on


Article content continued

Conservative health critic Michelle Rempel Garner said the Liberals had to come clean about the full details of the rollout, so Canadians could see how it stood up to scrutiny.

“When they say that every Canadian will have a dose of vaccine by September, what assumptions have they made on approval, timelines, and availability of other vaccine candidates and if those don’t come to pass what’s plan B?”

She said she wanted the government to succeed, so Canadians could get back to a normal life, but that clearly had not happened.

“I really don’t take any pleasure in saying that they haven’t delivered.”

According to the Bloomberg news service, as of Monday, Canada was 12th in the world on vaccines delivered on a per capita basis. Behind countries like Israel, the U.K. and the United States and the United Arab Emirates, as well as several small European countries.

Israel is the world leader so far having administered first doses to more than 25 per cent of its population primarily using the Pfizer vaccine. Several reports indicated the country had paid more for the vaccines than other countries. it also had agreed to share anonymized patient data from its health system with Pfizer.

The United Kingdom has approved the AstraZeneca vaccine and made it a major part of its rollout. The vaccine, which is not yet approved in either Canada or the United States, does not need to be kept frozen and is easier to distribute. Some countries, like the United Arab Emirates, that are ahead of Canada are using a vaccine from Sinopharm, a Chinese state company.

Trudeau was asked Tuesday why Canada hadn’t ordered more doses for the first quarter of the year. He said there were only so many doses available from the two approved candidates Pfizer and Moderna, before the vaccines were approved and manufacturing could ramp up.

“The challenge is, as of December 1, 2020, there were none of these vaccines being produced anywhere in the world for general use. They were all in testing and trials in the scientific community,” he said.

• Email: rtumilty@postmedia.com | Twitter:

Let’s block ads! (Why?)



Source link

Continue Reading

Trending